ZTS
Decouvert par les declarations du Congres
- Insiders
- —
- Total bought
- —
- Total sold
- —
- Last activity
- —
- Last synced
-
2026-08-04 10:23:03
Insider holdings as a share of total assets aren't available for this company.
Price (1 year)
Live chart from TradingView - pulls its own market data, independent of this site's database. Symbol resolution is best-effort (defaults to NASDAQ) since we don't store the exchange prefix.
Market snapshot
Signal
Neutral signal Scored 2026-08-03
ZTS presents solid financial foundations — strong liquidity (85) and positive fundamental trends (75) — but rising leverage and a lengthening operating cycle introduce meaningful balance sheet risk.
The first sentence of the analysis written for ZTS on 2026-08-03 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 70.5% | 69.1% | 68.3% | 67.8% | 68.3% | |
| Ebit Margin | 37.8% | 36.5% | 37.4% | 35.8% | 35.0% | |
| Ebitda Margin | 43.0% | 41.8% | 43.1% | 41.6% | 40.8% | |
| Operating Profit Margin | 38.0% | 36.6% | 35.9% | 36.2% | 36.0% | |
| Pretax Profit Margin | 35.5% | 33.8% | 34.4% | 32.9% | 32.0% | |
| Continuous Operations Profit Margin | 28.2% | 27.0% | 27.4% | 26.1% | 26.2% | |
| Net Profit Margin | 28.2% | 26.9% | 27.4% | 26.2% | 26.2% | |
| Bottom Line Profit Margin | 28.2% | 26.9% | 27.4% | 26.2% | 26.2% | |
| Current Ratio | 3.028 | 1.754 | 3.358 | 2.370 | 3.856 | |
| Quick Ratio | 1.941 | 1.079 | 2.001 | 1.630 | 2.786 | |
| Solvency Ratio | 0.260 | 0.315 | 0.305 | 0.245 | 0.266 | |
| Cash Ratio | 1.034 | 0.582 | 1.079 | 1.129 | 1.938 | |
| Price To Earnings Ratio | 20.866 | 29.786 | 38.852 | 32.494 | 56.883 | |
| Price To Earnings Growth Ratio | 2.038 | 3.880 | 3.074 | 6.336 | 2.302 | |
| Forward Price To Earnings Growth Ratio | 2.038 | 3.880 | 3.074 | 6.336 | 2.302 | |
| Price To Earnings Diluted Ratio | 20.900 | 29.786 | 38.929 | 32.639 | 57.150 | |
| Price To Earnings Diluted Growth Ratio | 2.079 | 3.775 | 3.014 | 6.335 | 2.299 | |
| Price To Book Ratio | 16.750 | 15.514 | 18.215 | 15.600 | 25.480 | |
| Price To Sales Ratio | 5.894 | 7.995 | 10.653 | 8.504 | 14.886 | |
| Price To Free Cash Flow Ratio | 24.439 | 32.203 | 56.151 | 51.822 | 66.679 | |
| Price To Operating Cash Flow Ratio | 19.213 | 25.060 | 38.683 | 35.939 | 52.307 | |
| Debt To Assets Ratio | 0.614 | 0.474 | 0.473 | 0.542 | 0.485 | |
| Debt To Equity Ratio | 2.850 | 1.414 | 1.352 | 1.837 | 1.484 | |
| Debt To Capital Ratio | 0.740 | 0.586 | 0.575 | 0.647 | 0.597 | |
| Long Term Debt To Capital Ratio | 0.735 | 0.523 | 0.568 | 0.598 | 0.592 | |
| Financial Leverage Ratio | 4.643 | 2.985 | 2.859 | 3.388 | 3.060 | |
| Working Capital Turnover Ratio | 2.664 | 2.634 | 1.943 | 1.706 | 1.624 | |
| Operating Cash Flow Ratio | 1.299 | 0.865 | 1.246 | 0.604 | 1.231 | |
| Operating Cash Flow Sales Ratio | 0.307 | 0.319 | 0.275 | 0.237 | 0.285 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.786 | 0.778 | 0.689 | 0.694 | 0.784 | |
| Debt Service Coverage Ratio | 11.426 | 2.032 | 11.835 | 1.770 | 11.517 | |
| Interest Coverage Ratio | 14.802 | 14.017 | 11.895 | 12.354 | 11.877 | |
| Short Term Operating Cash Flow Coverage Ratio | 54.792 | 2.187 | 784.333 | 1.414 | 0.000 | |
| Operating Cash Flow Coverage Ratio | 0.306 | 0.438 | 0.348 | 0.236 | 0.328 | |
| Capital Expenditure Coverage Ratio | 4.676 | 4.508 | 3.214 | 3.263 | 4.639 | |
| Dividend Paid And Capex Coverage Ratio | 1.923 | 2.049 | 1.652 | 1.597 | 2.327 | |
| Dividend Payout Ratio | 0.333 | 0.316 | 0.295 | 0.289 | 0.233 | |
| Enterprise Value Multiple | 15.477 | 20.341 | 25.980 | 21.807 | 37.521 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 70.5% | ▲1.4% | ▲1.7% |
| Ebit Margin | 37.8% | ▲1.4% | ▲1.3% |
| Ebitda Margin | 43.0% | ▲1.1% | ▲0.9% |
| Operating Profit Margin | 38.0% | ▲1.4% | ▲1.4% |
| Pretax Profit Margin | 35.5% | ▲1.6% | ▲1.8% |
| Continuous Operations Profit Margin | 28.2% | ▲1.3% | ▲1.3% |
| Net Profit Margin | 28.2% | ▲1.4% | ▲1.3% |
| Bottom Line Profit Margin | 28.2% | ▲1.4% | ▲1.3% |
| Current Ratio | 3.028 | ▲1.274 | ▲0.155 |
| Quick Ratio | 1.941 | ▲0.862 | ▲0.054 |
| Solvency Ratio | 0.260 | ▼-0.055 | ▼-0.018 |
| Cash Ratio | 1.034 | ▲0.453 | ▼-0.118 |
| Price To Earnings Ratio | 20.866 | ▼-8.920 | ▼-14.911 |
| Price To Earnings Growth Ratio | 2.038 | ▼-1.842 | ▼-1.488 |
| Forward Price To Earnings Growth Ratio | 2.038 | ▼-1.842 | ▼-1.488 |
| Price To Earnings Diluted Ratio | 20.900 | ▼-8.886 | ▼-14.981 |
| Price To Earnings Diluted Growth Ratio | 2.079 | ▼-1.697 | ▼-1.422 |
| Price To Book Ratio | 16.750 | ▲1.236 | ▼-1.562 |
| Price To Sales Ratio | 5.894 | ▼-2.102 | ▼-3.693 |
| Price To Free Cash Flow Ratio | 24.439 | ▼-7.764 | ▼-21.820 |
| Price To Operating Cash Flow Ratio | 19.213 | ▼-5.847 | ▼-15.028 |
| Debt To Assets Ratio | 0.614 | ▲0.140 | ▲0.096 |
| Debt To Equity Ratio | 2.850 | ▲1.436 | ▲1.063 |
| Debt To Capital Ratio | 0.740 | ▲0.154 | ▲0.111 |
| Long Term Debt To Capital Ratio | 0.735 | ▲0.212 | ▲0.132 |
| Financial Leverage Ratio | 4.643 | ▲1.659 | ▲1.256 |
| Working Capital Turnover Ratio | 2.664 | ▲0.030 | ▲0.550 |
| Operating Cash Flow Ratio | 1.299 | ▲0.434 | ▲0.250 |
| Operating Cash Flow Sales Ratio | 0.307 | ▼-0.012 | ▲0.022 |
| Free Cash Flow Operating Cash Flow Ratio | 0.786 | ▲0.008 | ▲0.040 |
| Debt Service Coverage Ratio | 11.426 | ▲9.394 | ▲3.710 |
| Interest Coverage Ratio | 14.803 | ▲0.786 | ▲1.813 |
| Short Term Operating Cash Flow Coverage Ratio | 54.792 | ▲52.605 | ▼-113.753 |
| Operating Cash Flow Coverage Ratio | 0.306 | ▼-0.132 | ▼-0.025 |
| Capital Expenditure Coverage Ratio | 4.676 | ▲0.168 | ▲0.616 |
| Dividend Paid And Capex Coverage Ratio | 1.923 | ▼-0.126 | ▲0.013 |
| Dividend Payout Ratio | 0.333 | ▲0.016 | ▲0.039 |
| Enterprise Value Multiple | 15.477 | ▼-4.865 | ▼-8.749 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $55.79B | $74.00B | $91.02B | $68.72B | $115.76B | |
| Enterprise value | $62.97B | $78.76B | $95.74B | $73.23B | $119.02B | |
| EV / Sales | 6.65x | 8.51x | 11.21x | 9.06x | 15.31x | |
| EV / Op. cash flow | 21.69x | 26.67x | 40.69x | 38.30x | 53.78x | |
| EV / Free cash flow | 27.58x | 34.27x | 59.06x | 55.23x | 68.56x | |
| EV / EBITDA | 15.48x | 20.34x | 25.98x | 21.81x | 37.52x | |
| Net debt / EBITDA | 1.76x | 1.23x | 1.28x | 1.34x | 1.03x | |
| Current ratio | 3.03x | 1.75x | 3.36x | 2.37x | 3.86x | |
| Income quality | 1.09x | 1.18x | 1.00x | 0.91x | 1.09x | |
| Graham number | $32 | $36 | $35 | $31 | $30 | |
| Graham net-net | -$17 | -$12 | -$11 | -$10 | -$9 | |
| Tax burden | 79.6% | 79.3% | 79.8% | 79.6% | 81.9% | |
| Interest burden | 93.8% | 92.8% | 91.9% | 91.8% | 91.3% | |
| Working capital | $4.53B | $2.57B | $4.45B | $4.34B | $5.13B | |
| Invested capital | $12.27B | $10.04B | $11.98B | $11.44B | $11.89B | |
| Return on assets | 17.3% | 17.5% | 16.4% | 14.2% | 14.7% | |
| Operating ROA | 24.2% | 23.8% | 21.0% | 20.3% | 20.4% | |
| Return on tangible assets | 22.8% | 23.9% | 23.0% | 19.6% | 20.9% | |
| Return on equity | 80.2% | 52.1% | 46.9% | 48.0% | 44.8% | |
| Return on invested capital | 21.5% | 22.2% | 19.7% | 17.8% | 18.9% | |
| Return on capital employed | 27.2% | 31.3% | 24.8% | 24.9% | 23.2% | |
| Earnings yield | 4.8% | 3.4% | 2.6% | 3.1% | 1.8% | |
| Free cash flow yield | 4.1% | 3.1% | 1.8% | 1.9% | 1.5% | |
| Capex / Op. cash flow | 21.4% | 22.2% | 31.1% | 30.6% | 21.6% | |
| Capex / Depreciation | 127.5% | 131.8% | 149.1% | 126.0% | 106.5% | |
| Capex / Sales | 6.6% | 7.1% | 8.6% | 7.3% | 6.1% | |
| SG&A / Sales | 25.1% | 25.0% | 25.2% | 24.9% | 25.7% | |
| R&D / Sales | 7.4% | 7.4% | 7.2% | 6.7% | 6.5% | |
| Stock comp / Sales | 0.9% | 0.8% | 0.7% | 0.8% | 0.7% | |
| Intangibles / Total assets | 24.3% | 27.0% | 28.7% | 27.6% | 29.9% | |
| Days sales outstanding | 61d | 52d | 56d | 55d | 53d | |
| Days payables outstanding | 64d | 55d | 55d | 57d | 65d | |
| Operating cycle | 379d | 346d | 401d | 384d | 338d | |
| Cash conversion cycle | 315d | 291d | 346d | 327d | 273d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Change over 5 years
Employee count
Peer market caps
Congressional trades
Recent trades
| Date | Representative | Type | Amount |
|---|---|---|---|
| 2026-06-16 | Gilbert Cisneros | Purchase | $1,001 - $15,000 |
| 2026-06-09 | Byron Donalds | Purchase | $1,001 - $15,000 |
| 2026-06-09 | Byron Donalds | Purchase | $1,001 - $15,000 |
| 2026-06-09 | Charles J. "Chuck" Fleischmann | Purchase | $15,001 - $50,000 |
| 2026-05-01 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2026-02-10 | Gilbert Cisneros | Purchase | $1,001 - $15,000 |
| 2026-01-29 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2026-01-13 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2025-12-19 | Gilbert Cisneros | Purchase | $1,001 - $15,000 |
| 2025-11-18 | Gilbert Cisneros | Purchase | $1,001 - $15,000 |
| 2025-10-27 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2025-10-27 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2025-10-07 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2025-10-06 | Rick Larsen | Sale | $1,001 - $15,000 |
| 2025-09-29 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2025-09-26 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2025-09-15 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2025-09-05 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2025-08-27 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2025-08-26 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2025-08-21 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2025-08-06 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2025-08-05 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2025-08-05 | Gilbert Cisneros | Sale (Partial) | $1,001 - $15,000 |
| 2025-08-04 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2025-07-22 | Lisa McClain | Purchase | $1,001 - $15,000 |
| 2025-05-15 | Rob Bresnahan | Purchase | $1,001 - $15,000 |
| 2025-04-08 | Rob Bresnahan | Sale | $1,001 - $15,000 |
| 2025-03-27 | Greg Landsman | Sale | $1,001 - $15,000 |
| 2025-03-03 | Julie Johnson | Sale | $1,001 - $15,000 |
| 2025-01-15 | Lisa McClain | Sale (Full) | $1,001 - $15,000 |
| 2024-12-11 | Lisa McClain | Purchase | $1,001 - $15,000 |
| 2024-07-05 | Jared Moskowitz | Sale (Full) | $1,001 - $15,000 |
| 2024-03-25 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2024-03-20 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2024-02-13 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2024-02-13 | Ro Khanna | Sale | $50,001 - $100,000 |
| 2024-01-20 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2024-01-10 | Ro Khanna | Sale | $15,001 - $50,000 |
| 2024-01-09 | Rick Larsen | Purchase | $1,001 - $15,000 |
| 2023-12-28 | Jared Moskowitz | Purchase | $1,001 - $15,000 |
| 2023-12-04 | John Curtis | Sale | $1,001 - $15,000 |
| 2023-10-24 | Greg Stanton | Sale | $1,001 - $15,000 |
| 2023-09-29 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2023-09-29 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2023-09-26 | Greg Stanton | Purchase | $1,001 - $15,000 |
| 2023-07-21 | Robert J. Wittman | Purchase | $1,001 - $15,000 |
| 2023-07-14 | Daniel Goldman | Sale | $1,001 - $15,000 |
| 2023-06-13 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2023-06-13 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2023-05-25 | Zoe Lofgren | Sale | $1,001 - $15,000 |
| 2023-05-23 | Ro Khanna | Sale | $15,001 - $50,000 |
| 2023-04-10 | Daniel Goldman | Sale | $1,001 - $15,000 |
| 2023-03-14 | Ro Khanna | Purchase | $15,001 - $50,000 |
| 2023-03-07 | Daniel Goldman | Purchase | $1,001 - $15,000 |
| 2023-03-06 | Daniel Goldman | Purchase | $1,001 - $15,000 |
| 2023-01-31 | Daniel Goldman | Purchase | $1,001 - $15,000 |
| 2023-01-09 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-12-20 | John Curtis | Purchase | $1,001 - $15,000 |
| 2022-12-06 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-12-06 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2022-12-05 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2022-10-20 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2022-10-11 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2022-09-29 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-08-26 | Alan S. Lowenthal | Purchase | $15,001 - $50,000 |
| 2022-08-01 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-06-28 | John Curtis | Purchase | $1,001 - $15,000 |
| 2022-05-23 | Ro Khanna | Purchase | $15,001 - $50,000 |
| 2022-05-10 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2022-05-04 | Michael McCaul | Sale | $100,001 - $250,000 |
| 2022-05-04 | Michael McCaul | Sale | $100,001 - $250,000 |
| 2022-04-21 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-04-13 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2022-04-11 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2022-04-05 | Ro Khanna | Sale | $15,001 - $50,000 |
| 2022-03-08 | Dan Newhouse | Purchase | $1,001 - $15,000 |
| 2022-02-17 | Ro Khanna | Sale | $50,001 - $100,000 |
| 2022-02-10 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2022-01-28 | Michael McCaul | Sale | $1,001 - $15,000 |
| 2022-01-28 | Michael McCaul | Sale | $1,001 - $15,000 |
| 2022-01-26 | Michael McCaul | Sale | $50,001 - $100,000 |
| 2022-01-26 | Michael McCaul | Sale | $50,001 - $100,000 |
| 2022-01-21 | Ro Khanna | Purchase | $15,001 - $50,000 |
| 2022-01-11 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2022-01-06 | Kurt Schrader | Sale (Full) | $1,001 - $15,000 |
| 2021-12-21 | Michael McCaul | Sale | $15,001 - $50,000 |
| 2021-12-14 | Michael McCaul | Sale | $1,001 - $15,000 |
| 2021-09-02 | Zoe Lofgren | Purchase | $1,001 - $15,000 |
| 2021-08-09 | Zoe Lofgren | Purchase | $1,001 - $15,000 |
| 2021-02-16 | Peter Meijer | Sale (Full) | $1,001 - $15,000 |
| 2020-11-25 | Michael McCaul | Sale (Full) | $15,001 - $50,000 |
| 2020-11-25 | Michael McCaul | Purchase | $15,001 - $50,000 |
| 2020-08-07 | Joe Courtney | Sale (Full) | $1,001 - $15,000 |
| 2020-07-21 | Alan S. Lowenthal | Sale (Partial) | $1,001 - $15,000 |
| 2020-03-27 | John Curtis | Purchase | $1,001 - $15,000 |
| 2020-03-23 | Zoe Lofgren | Sale (Full) | $1,001 - $15,000 |
| 2020-02-27 | Alan S. Lowenthal | Purchase | $15,001 - $50,000 |
| 2019-12-31 | Joe Courtney | Purchase | $1,001 - $15,000 |
| 2019-12-18 | John B. Larson | Sale (Full) | $15,001 - $50,000 |
Recent news
- 2026-08-03 ZTS Set to Report Q2 Earnings: Here''s What Investors Should Expect Zoetis heads into Q2 earnings with companion animal products and international growth in focus as U.S. competition and Librela concerns weigh.
- 2026-07-27 Zoetis (ZTS) Beats Stock Market Upswing: What Investors Need to Know In the closing of the recent trading day, Zoetis (ZTS) stood at $76.92, denoting a +2.08% move from the preceding trading day.
- 2026-07-27 ZTS DEADLINE TODAY: ROSEN, A LEADING NATIONAL FIRM, Encourages Zoetis Inc. Investors to Secure Counsel Before Important July 27 Deadline in Securities Class Action - ZTS New York, New York--(Newsfile Corp. - July 27, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Zoetis Inc. (NYSE: ZTS) between January 14, 2025 and May 6, 2026, inclusive (the "Class Period"), of the important July 27, 2026 lead plaintiff deadline. SO WHAT: If you purchased Zoetis securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
- 2026-07-27 Bronstein, Gewirtz & Grossman LLC Urges Zoetis Inc. Investors to Act: Class Action Filed Alleging Investor Harm New York, New York--(Newsfile Corp. - July 27, 2026) - Bronstein, Gewirtz and Grossman, LLC, a nationally recognized investor-rights law
- 2026-07-27 Bronstein, Gewirtz & Grossman LLC Urges Zoetis Inc. Investors to Act: Class Action Filed Alleging Investor Harm NEW YORK, July 27, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Zoetis Inc. (NYSE: ZTS) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Zoetis securities between January 14, 2025 and May 6, 2026, both dates inclusive (the “Class Period”).
- 2026-07-24 Zoetis Inc. (ZTS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit Zoetis Inc. (ZTS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit PR Newswire LOS
- 2026-07-24 Zoetis Inc. (ZTS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit LOS ANGELES, July 24, 2026 /PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Zoetis Inc. ("Zoetis" or the "Company") (NYSE: ZTS). IF YOU SUFFERED A LOSS ON YOUR ZOETIS INVESTMENTS, CLICK HERE BEFORE JULY 27, 2026 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT What Is The Lawsuit About?
- 2026-07-24 ZOETIS CLASS ACTION DEADLINE MONDAY JULY 27th: Bragar Eagel & Squire, P.C. Reminds Zoetis, Inc. Investors to Contact the Firm Before the July 27th Lead Plaintiff Deadline Bragar Eagel & Squire, P.C. Litigation Partners Brandon Walker and Melissa Fortunato Encourage Investors Who Suffered Losses In Zoetis (ZTS) To Contact Them Directly To Discuss Their Options
- 2026-07-24 ZTS Shareholder Alert: Zoetis Inc. Securities Class Action Lawsuit - Investors With Losses May Contact The Gross Law Firm NEW YORK, July 24, 2026 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Zoetis Inc. (NYSE: ZTS).
- 2026-07-24 Zoetis: Sentiment Keeps Winning As Fundamentals Improve Zoetis Inc. trades at a 45% discount to fair value despite resilient fundamentals and long-term growth prospects. ZTS''s Q1 2026 saw 2.9% revenue growth and 8.5% adjusted EPS growth, with livestock offsetting domestic pet care weakness. Forward P/E of 10.5 is well below its 10-year average; a fair value multiple of 19 is justified given a 7.5% EPS growth consensus.